Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
BAYER AG
🇩🇪
Germany
Country
🇩🇪
Germany
Ownership
Public
Established
1863-08-01
Employees
99.7K
Market Cap
$30.1B
Website
http://www.bayer.com
Clinical Trials
Related News
Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension
Phase 3
Completed
Conditions
Erectile Dysfunction
Interventions
Drug: Placebo
Drug: Levitra (Vardenafil, BAY38-9456)
Subscribe
First Posted Date
2008-04-28
Last Posted Date
2014-12-16
Lead Sponsor
Bayer
Target Recruit Count
388
Registration Number
NCT00668005
Subscribe
Ciprofloxacin on Burned Patients
Phase 3
Completed
Conditions
Burns
Bacterial Infections
Interventions
Drug: Ciprofloxacin (BAYO9867)
Subscribe
First Posted Date
2008-04-28
Last Posted Date
2009-10-27
Lead Sponsor
Bayer
Target Recruit Count
18
Registration Number
NCT00668044
Subscribe
PK in Pts With HRPC & Skeletal Metastes
Phase 1
Completed
Conditions
Prostatic Neoplasms
Interventions
Drug: Radium-223 chloride (Xofigo®, BAY88-8223) injection
Subscribe
First Posted Date
2008-04-28
Last Posted Date
2015-12-14
Lead Sponsor
Bayer
Target Recruit Count
6
Registration Number
NCT00667537
Subscribe
Assess Efficacy in Subjects With Traumatic Spinal Cord Injury
Phase 4
Completed
Conditions
Spinal Cord Injury
Erectile Dysfunction
Interventions
Drug: Vardenafil (Levitra, BAY 38-9456), 10 mg
Drug: Placebo
Drug: Vardenafil (Levitra, BAY 38-9456), 20 mg
Subscribe
First Posted Date
2008-04-28
Last Posted Date
2015-05-06
Lead Sponsor
Bayer
Target Recruit Count
45
Registration Number
NCT00667966
Subscribe
BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration.
Phase 3
Completed
Conditions
Erectile Dysfunction
Interventions
Drug: Levitra (Vardenafil, BAY38-9456)
Drug: Placebo
Subscribe
First Posted Date
2008-04-28
Last Posted Date
2015-03-06
Lead Sponsor
Bayer
Target Recruit Count
624
Registration Number
NCT00668057
Subscribe
A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.
Phase 4
Completed
Conditions
Erectile Dysfunction
Interventions
Drug: Placebo
Drug: Levitra (Vardenafil, BAY38-9456)
Subscribe
First Posted Date
2008-04-28
Last Posted Date
2014-12-25
Lead Sponsor
Bayer
Target Recruit Count
260
Registration Number
NCT00668096
Subscribe
BAY88-8223, Does Response Study in HRPC Patients
Phase 2
Completed
Conditions
Hormone Refractory Prostate Cancer
Bone Metastases
Interventions
Drug: Radium-223 dichloride (BAY88-8223)
Subscribe
First Posted Date
2008-04-28
Last Posted Date
2023-04-19
Lead Sponsor
Bayer
Target Recruit Count
100
Registration Number
NCT00667199
Subscribe
Vardenafil in Tinnitus
Phase 2
Completed
Conditions
Tinnitus
Interventions
Drug: Levitra (Vardenafil, BAY38-9456)
Drug: Placebo
Subscribe
First Posted Date
2008-04-25
Last Posted Date
2014-12-09
Lead Sponsor
Bayer
Target Recruit Count
43
Registration Number
NCT00666809
Subscribe
A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction
Phase 3
Completed
Conditions
Erectile Dysfunction
Interventions
Drug: Placebo
Drug: Levitra (Vardenafil, BAY38-9456)
Subscribe
First Posted Date
2008-04-24
Last Posted Date
2014-12-17
Lead Sponsor
Bayer
Target Recruit Count
732
Registration Number
NCT00665496
Subscribe
Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED)
Phase 4
Completed
Conditions
Erectile Dysfunction
Interventions
Drug: Levitra (Vardenafil, BAY38-9456)
Drug: Placebo
Subscribe
First Posted Date
2008-04-23
Last Posted Date
2013-10-11
Lead Sponsor
Bayer
Target Recruit Count
219
Registration Number
NCT00665340
Subscribe
Prev
1
137
138
139
140
141
162
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy